Tzimycycle (Cimiciklim)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspfilm coated tablets
Composition:

Composition per one tablet

Active substance

Tsimitsifugi extract dry - 0.020 g

with the content of the sum of triterpene aglikons in terms of amirin and dry matter 1.5%

Auxiliary substances of the core

Lactose monohydrate - 0.09685 g

Povidone (low molecular weight polyvinylpyrrolidone, povidone K-17) - 0.00250 g

Magnesium stearate -0,00120 g

Talc-0.00070 g

Shell accessories

Giprolase (hydroxypropyl cellulose) 0.00192 g

Titanium dioxide - 0.00131 g

Macrogol 6000 (polyethylene glycol 6000) - 0.00052 g.

Description:

Tablets are round, biconcave, film-coated, white.

Pharmacotherapeutic group:An antimalaymic agent of plant origin
ATX: & nbsp
  • Other drugs for use in gynecology
    • Pharmacodynamics:

    Has an estrogen-like effect, shows sedative properties, has a positive therapeutic effect on the autonomic nervous system, contributes to the weakening or complete disappearance of the symptoms of malaise in the climacteric period. The therapeutic effect comes gradually and manifests itself after about 2 weeks of treatment.

    Pharmacokinetics:

    No data available.

    Indications:

    Vegeto-vascular and psychoemotional disorders in the period of menopause, pre- and postmenopausal ("hot flashes", excessive sweating, sleep disturbances, increased nervous excitability,mood changes, apathy, etc.).

    Contraindications:

    Hypersensitivity to the drug components, estrogen-dependent tumors, pregnancy, the period of breastfeeding, lactase deficiency, lactose intolerance, glucose-galactose malabsorption, age to 18 years.

    Carefully:

    Dysfunction of the liver, epilepsy, diseases and brain trauma.

    If you have any of these diseases, consult a doctor before taking the drug.

    Pregnancy and lactation:

    Contraindicated use of the drug during pregnancy and during breastfeeding.

    Dosing and Administration:

    Inside, 1 tablet 2 times a day at the same time of day (morning and evening). Tablets should be swallowed, not liquid, squeezed with a small amount of water.

    The duration of treatment is determined by the doctor.

    Side effects:

    Allergic reactions.

    In rare cases, there may be pain in the epigastric region and an increase in body weight. Very rarely there is a feeling of tension in the mammary glands and menstrual like bleeding.

    If any of the side effects listed in the manual are aggravated, or if you notice any other side effects not listed in the instructions, inform the doctor about it.

    Overdose:

    To date, cases of overdose have not been reported.

    Interaction:

    Interaction with other drugs is currently unknown.

    Special instructions:

    Before using the drug, you should consult your doctor. Without consulting a doctor, the drug should not be taken for more than 3 months.

    At the onset of pregnancy, it is necessary to stop taking the drug and consult a doctor.

    When changing the nature of the menstrual cycle, as well as with prolonged or other newly arising complaints, you should consult a doctor.

    Patients with diabetes and people on a diet with a reduced carbohydrate diet should take into account that one tablet contains about 0.114 grams of carbohydrates (0.0095 XE).

    Effect on the ability to drive transp. cf. and fur:

    The use of the drug does not affect the ability to drive vehicles and engage in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

    Form release / dosage:Tablets, film-coated, 20 mg.
    Packaging:

    For 10 or 20 tablets in a contour mesh package.2, 4 or 6 out-of-round cell packs of 10 tablets or 1, 2 or 3 contour packs of 20 tablets together with the instructions for use are placed in a pack of cardboard.

    Storage conditions:

    In a dry, protected from light place at a temperature of no higher than 25 ° C. Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-004301
    Date of registration:18.05.2017
    Expiration Date:18.05.2022
    The owner of the registration certificate:VIFITEH, CJSC VIFITEH, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp21.06.2017
    Illustrated instructions
      Instructions
      Up